Skip to content

Clinical trials

Phase 3 Diabetes Mellitus, Type 2 trials in Norway

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Phase: Phase 3 Country / region: Norway Clear all

55 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20033
20046
20054
20062
20073
20085
20095
20104
20112
20121
20134
20141
20152
20162
20173
20181
20201
20221
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed44
Terminated9
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S19
AstraZeneca10
Boehringer Ingelheim9
Sanofi4
Bayer2
Janssen Research & Development, LLC2
Novartis2
Novartis Pharmaceuticals2
GlaxoSmithKline1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 255
Diabetes Mellitus22
Cardiovascular Diseases3
Hypertension3
Diabetic Nephropathies2
Kidney Diseases2
Renal Insufficiency, Chronic2
Coronary Artery Disease1
Dyslipidemias1
Glucose Intolerance1

Trials

Showing 1 to 25 of 55. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.